DB Healthcare SRL
DB Healthcare reported total assets of 102,692 € at the end of the 2025 financial year (annual accounts filed with the NBB on 16 Jun 2026).
The score of DB Healthcare shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -49 % Total assets -37 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
DB Healthcare's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 16 Jun 2026
- Year ended 31 Dec 2024filed on 15 Jun 2025
- Year ended 31 Dec 2023filed on 07 Aug 2024
- Year ended 31 Dec 2022filed on 07 Jul 2023
- Year ended 31 Dec 2021filed on 29 Jun 2022
DB Healthcare's financial analysis
- Solvency49.6%sector median: 31.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of DB Healthcare
DB Healthcare's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0878.675.191
- VAT number
- No VAT activity declared to the CBE
- Peppol
- Registered · 0208:0878675191 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 04 Jan 2006
- Registered office
- 9200 Dendermonde
- Latest accounts
- 2025 · filed on 16 Jun 2026
- Activity
- Manufacture of perfume and toilet preparations (NACE 2042004)
DB Healthcare (SRL) has been based in Dendermonde since 2006, active in: manufacture of perfume and toilet preparations. For 2025, it reports a net loss of 13,016 € and equity of 50,894 €; its revenue is not published. Its solvency stands at 49.6%, above the median of its sector (31.9%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to DB Healthcare
Companies in the same business, of comparable size and area, outside its group.
- Medic Skin Care Manufacture of perfume and toilet preparations Antwerp · balance sheet 110,028 €
- Elementics Natural Manufacture of perfume and toilet preparations Dilsen-Stokkem · balance sheet 86,859 €
- Bestiale Makeup Manufacture of perfume and toilet preparations Ans · balance sheet 211,328 €
- Unveiled Manufacture of perfume and toilet preparations Etterbeek · balance sheet 62,239 €
- Artéssence Manufacture of perfume and toilet preparations Brussels · balance sheet 63,683 €
- Ô & Sens Manufacture of perfume and toilet preparations Seraing · balance sheet 58,801 €
- La Maisonnette Manufacture of perfume and toilet preparations Welkenraedt · balance sheet 223,182 €
- Misoty Manufacture of perfume and toilet preparations Anderlecht · balance sheet 46,150 €
Frequently asked questions about DB Healthcare
What is the revenue of DB Healthcare?
DB Healthcare files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of DB Healthcare?
According to the Crossroads Bank for Enterprises, no VAT-liable activity is declared for DB Healthcare. If it is VAT-registered, its VAT number is its company number prefixed with BE: BE0878675191. Its company number (CBE) is 0878.675.191.
Where is the registered office of DB Healthcare?
According to the CBE register, the registered office of DB Healthcare is in 9200 Dendermonde.
What is the equity of DB Healthcare?
At the close of the 2025 financial year, the equity of DB Healthcare amounts to 50,894 €, a solvency of 49.6% of total assets.
Who manages DB Healthcare?
The register lists 2 active mandates at DB Healthcare. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of DB Healthcare
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →